Article Details
Retrieved on: 2023-09-22 22:50:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a second action, BioNTech SE (“BioNTech”) and Pfizer Inc. (“Pfizer”) filed inter partes review (IPR) petitions before the Patent Trial and ...
Article found on: www.jdsupra.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here